The role of transcriptional coactivator TRAP220 in myelomonocytic differentiation
暂无分享,去创建一个
R. Roeder | K. Chihara | T. Matsui | Katsuya Yamamoto | K. Minagawa | K. Yakushijin | A. Okamura | A. Sada | N. Urahama | A. Hato | M. Ito | Norinaga Urahama
[1] R. Roeder,et al. Dynamic regulation of pol II transcription by the mammalian Mediator complex. , 2005, Trends in biochemical sciences.
[2] Joan W Conaway,et al. The mammalian Mediator complex and its role in transcriptional regulation. , 2005, Trends in biochemical sciences.
[3] Roger D Kornberg,et al. Mediator and the mechanism of transcriptional activation. , 2005, Trends in biochemical sciences.
[4] V. Kouskoff,et al. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo , 2004, Nature.
[5] P. Chambon,et al. Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. , 2004, The Journal of investigative dermatology.
[6] A. Burlingame,et al. Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation. , 2003, Molecular endocrinology.
[7] R. Tjian,et al. Transcription regulation and animal diversity , 2003, Nature.
[8] K. Flanders,et al. Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells. , 2003, Blood.
[9] A. Näär,et al. A component of the ARC/Mediator complex required for TGFβ/Nodal signalling , 2002, Nature.
[10] R. Darnell,et al. The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development , 2002, The EMBO journal.
[11] B. Spiegelman,et al. Transcription coactivator TRAP220 is required for PPARγ2-stimulated adipogenesis , 2002, Nature.
[12] A. Friedman. Transcriptional regulation of granulocyte and monocyte development , 2002, Oncogene.
[13] D. Engelke,et al. Effective expression of small interfering RNA in human cells , 2002, Nature Biotechnology.
[14] H. Koeffler,et al. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. , 2002, The Journal of clinical investigation.
[15] J. D. Engel,et al. Defects of the Heart, Eye, and Megakaryocytes in Peroxisome Proliferator Activator Receptor-binding Protein (PBP) Null Embryos Implicate GATA Family of Transcription Factors* , 2002, The Journal of Biological Chemistry.
[16] S. Asano,et al. Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells. , 2001, Blood.
[17] R. Roeder,et al. The TRAP/SMCC/Mediator complex and thyroid hormone receptor function , 2001, Trends in Endocrinology & Metabolism.
[18] N. Messaddeq,et al. RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. , 2001, Development.
[19] N. Fortunel,et al. Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis , 2000 .
[20] M. Demay,et al. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. , 2000, Endocrinology.
[21] J. Reddy,et al. Deletion of PBP/PPARBP, the Gene for Nuclear Receptor Coactivator Peroxisome Proliferator-activated Receptor-binding Protein, Results in Embryonic Lethality* , 2000, The Journal of Biological Chemistry.
[22] R. Darnell,et al. Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. , 2000, Molecular cell.
[23] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[24] J. Qin,et al. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. , 1999, Molecules and Cells.
[25] R. Roeder,et al. The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] L. Zon,et al. Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation. , 1998, Blood.
[27] M. Yoder,et al. In vivo repopulating hematopoietic stem cells are present in the murine yolk sac at day 9.0 postcoitus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Ptashne,et al. Transcriptional activation by recruitment , 1997, Nature.
[29] G. Keller,et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis , 1997, Nature.
[30] H. DeLuca,et al. Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. , 1995, Biochimica et biophysica acta.
[31] S. Orkin,et al. GATA transcription factors: key regulators of hematopoiesis. , 1995, Experimental hematology.
[32] A. Cumano,et al. Emergence of multipotent hemopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] F. Lund-Johansen,et al. Expression of cell surface antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3, retinoic acid and DMSO. , 1995, Leukemia research.
[34] M. Andreeff,et al. Retinoic Acid-induced Expression of CD38 Antigen in Myeloid Cells Is Mediated through Retinoic Acid Receptor-α , 1994 .
[35] C. Chomienne,et al. Retinoid acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. , 1993, Leukemia.
[36] C. Peschle,et al. Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines. , 1993, Journal of immunology.
[37] F. Ruscetti,et al. Synergy between Transforming Growth Factor‐β and Tumor Necrosis Factor‐α in the Induction of Monocytic Differentiation of Human Leukemic Cell Lines a , 1990 .
[38] F. Ruscetti,et al. Synergy between transforming growth factor-beta and tumor necrosis factor-alpha in the induction of monocytic differentiation of human leukemic cell lines , 1990 .
[39] S. Collins,et al. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. , 1987, Blood.
[40] D. Kufe,et al. Expression of the c-fms proto-oncogene during human monocytic differentiation , 1985, Nature.
[41] H. DeLuca,et al. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. , 1984, Cancer research.
[42] T. Matsui,et al. Phenotypic differentiation‐linked growth inhibition in human leukemia cells by active vitamin D3 analogues , 1984, International Journal of Cancer.
[43] T. Nakahata,et al. Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[44] S. Collins,et al. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.